Active Ingredient(s): Elagolix Sodium
FDA Approved: * July 23, 2018
Pharm Company: * ABBVIE INC
Category: Women's Health / Fertility

Elagolix, sold under the brand name Orilissa, is a gonadotropin-releasing hormone antagonist (GnRH antagonist) medication which is used in the treatment of pain associated with endometriosis in women.[1][5][6][4][2][7][8] It is also under development for the treatment of uterine fibroids and heavy menstrual bleeding in women.[8] The medication was under investigation... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Orilissa 150 mg Oral Tablet, Film Coated
NDC: 0074-0038
Abbvie Inc.
Orilissa 200 mg Oral Tablet, Film Coated
NDC: 0074-0039
Abbvie Inc.